Mitochondrial ROS in the prohypertensive immune response.

Area of Science:

• Immunology
• Cardiovascular Disease
• Cellular Metabolism

Background:

• Reactive oxygen species (ROS) and inflammation are increasingly recognized in hypertension pathogenesis.
• Mitochondrial superoxide scavenging and blocking IL-17 or TNF-α reduce hypertension.
• T-cells are key players in hypertension, exhibiting cytokine production, proliferation, and differentiation upon activation.

Purpose of the Study:

• To review the role of mitochondrial ROS (mtROS) in T-cell activation and metabolic reprogramming.
• To present evidence supporting mtROS's direct contribution to prohypertensive immune responses.

Main Methods:

• Literature review summarizing existing data on ROS, inflammation, and hypertension.
• Analysis of T-cell activation, metabolic shifts, and mtROS production.

Main Results:

• T-cell activation increases energy demands, leading to metabolic phenotype alterations.
• Mitochondrial ROS (mtROS) are integral to these tightly regulated metabolic changes in T-cells.
• Evidence suggests mtROS directly promotes prohypertensive immune cell responses.

Conclusions:

• Mitochondrial ROS (mtROS) play a direct role in the prohypertensive functions of immune cells.
• Understanding the mtROS-immune cell-hypertension axis offers novel therapeutic targets.